- Home
- BHC vs CLM Comparison
BHC vs CLM Comparison
Compare BHC & CLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BHC | CLM |
|---|---|---|
| Founded | N/A | N/A |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.3B |
| IPO Year | 1996 | 1995 |
Fundamental Metrics
Financial Performance| Metric | BHC | CLM |
|---|---|---|
| Price | $5.37 | $7.35 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.33 | N/A |
| AVG Volume (30 Days) | 1.5M | ★ 1.5M |
| Earning Date | 04-29-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 423.08 | N/A |
| EPS | ★ 0.42 | N/A |
| Revenue | ★ $8,724,000,000.00 | N/A |
| Revenue This Year | $4.48 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $12.77 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.28 | $6.57 |
| 52 Week High | $8.69 | $8.53 |
Technical Indicators
Market Signals| Indicator | BHC | CLM |
|---|---|---|
| Relative Strength Index (RSI) | 49.11 | 47.49 |
| Support Level | $4.93 | $7.29 |
| Resistance Level | $7.22 | $8.22 |
| Average True Range (ATR) | 0.18 | 0.13 |
| MACD | 0.08 | 0.03 |
| Stochastic Oscillator | 60.87 | 79.25 |
Price Performance
Historical ComparisonAbout BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
About CLM Cornerstone Strategic Value Fund Inc. New
Cornerstone Strategic Value Fund Inc is a closed-end management investment company. The fund's objective is to seek long-term capital appreciation through investments in equity securities of U.S. and non-U.S. companies. It invests in various sectors, which include financials, information technology, healthcare, consumer discretionary, industrials, utilities, energy, telecommunication services, materials, and other sectors.